HOME
RESEARCH
TEAM
PUBLICATIONS
NEWS
GALLERY
CONTACT US
Dipanjan Chowdhury Lab
CHIEF OF THE DIVISION OF RADIATION AND GENOME STABILITY
Chowdhury Lab News
Dr. Dipanjan Chowdhury's presentation at Ovarcome's 2021 Annual Conference OVARCOMING CANCER
Boston researchers study early detection ovarian cancer blood test
Shrabasti Roychoudhury joins the lab as a post-doctoral fellow
Sarah Wilkins joins the lab as a research technician
Ngoc (Anna) Nyugen joins the lab as a research technician
Gray Foundation grant awarded for research into BRCA-related cancers
Sotirios Sotiriou awarded Swiss National Science Postdoc Mobility Fellowship
Study Finds Source of PARP Inhibitor Drug Resistance
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in
BRCA2
-Mutated Carcinomas
Katherine Choe awarded American Cancer Society Postdoctoral Fellowship
Inside the Institute spotlight: Research Points Way to Blood Test for Ovarian Cancer
New Blood Test Develo
ped to Diagno
se Ovarian Cancer
Detecting Radiation Exposure with a Blood Test. Scientific American, May 16, 2017
Katherine Choe, Ph.D. joins the lab as a post-doctoral fellow
Yizhou He, Ph.D. awarded the AACR-AstraZeneca Ovarian Cancer Research Fellowship
Dr. Chowdhury Appointed Chief of the Division of Radiation and Cancer Biology at Dana-Farber
Serum MicroRNA Signature Reflects Radiation Exposure, Lethality. Genome Web, Mar 07, 2017
Tina's Wish Benefit Raises $1.4M for Early Detection Ovarian Cancer Research at the American Museum of Natural History. PR Newswire, Sep 29, 2016
Novel cause of ovarian cancer drug resistance identified. Dana-Farber, January 07, 2016
Exposed to dangerous radiation? Telltale signs are in your blood. Science, May. 13, 2015
This Quick Genetic Test Could Predict a Person's Radiation Damage After a Disaster. Popular Mechanics, May 13, 2015
MicroRNA discovered to play role in DNA repair. Dana-Farber, April 19, 2010
Tweets by ChowdhuryLab